Pliant Therapeutics (PLRX) Earnings Date & Reports

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PLRX is expected to report earnings to fall 6.48% to -76 cents per share on May 12

Pliant Therapeutics PLRX Stock Earnings Reports

Q1'25

Est.

$-0.77

Q4'24

Beat

by $0.17

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.07

Q1'24

Missed

by $0.01

The last earnings report on March 03 showed earnings per share of -81 cents, beating the estimate of -99 cents. With 1.10M shares outstanding, the current market capitalization sits at 80.53M.

View a ticker or compare two or three

Compare

PLRX